The 3rd Annual US-China Pharma conference will focus on a variety of topics, such as how to shrewdly adapt to China’s new healthcare system and protect and profit from intellectual property, to profitably pricing and marketing brand, generic and biosimilar products.
WilmerHale Counsel Henry Gu will participate on a panel titled “Protecting and Enforcing Your Intellectual Property Rights in China.”
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
